Debt-to-equity of Bionano Genomics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bionano Genomics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Bionano Genomics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 74%, a 19% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Bionano Genomics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 74% -18% -19% 30 Sep 2025
Q2 2025 79% -1.6% -2% 30 Jun 2025
Q1 2025 75% +14% +22% 31 Mar 2025
Q4 2024 82% +37% +83% 31 Dec 2024
Q3 2024 91% +62% +212% 30 Sep 2024
Q2 2024 81% +58% +263% 30 Jun 2024
Q1 2024 61% +42% +224% 31 Mar 2024
Q4 2023 45% +30% +192% 31 Dec 2023
Q3 2023 29% +16% +128% 30 Sep 2023
Q2 2023 22% +12% +115% 30 Jun 2023
Q1 2023 19% +11% +138% 31 Mar 2023
Q4 2022 15% +8.9% +135% 31 Dec 2022
Q3 2022 13% +5.8% +82% 30 Sep 2022
Q2 2022 10% -0.88% -7.8% 30 Jun 2022
Q1 2022 7.9% -15% -65% 31 Mar 2022
Q4 2021 6.6% -182% -97% 31 Dec 2021
Q3 2021 7% -485% -99% 30 Sep 2021
Q2 2021 11% +4580% 30 Jun 2021
Q1 2021 23% +1128% 31 Mar 2021
Q4 2020 188% -13437% -99% 31 Dec 2020
Q3 2020 492% -764% -61% 30 Sep 2020
Q2 2020 -4569% -4837% -1800% 30 Jun 2020
Q1 2020 -1105% 31 Mar 2020
Q4 2019 13625% 31 Dec 2019
Q3 2019 1256% 30 Sep 2019
Q2 2019 269% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.